STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 97 filers reported holding STOKE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,879,000 | -5.7% | 120,000 | 0.0% | 0.08% | +6.6% |
| Q3 2021 | $3,053,000 | -24.4% | 120,000 | 0.0% | 0.08% | -26.2% |
| Q2 2021 | $4,039,000 | -13.3% | 120,000 | 0.0% | 0.10% | -25.9% |
| Q1 2021 | $4,661,000 | -37.3% | 120,000 | 0.0% | 0.14% | -36.8% |
| Q4 2020 | $7,432,000 | +84.9% | 120,000 | 0.0% | 0.22% | +22.2% |
| Q3 2020 | $4,019,000 | +40.5% | 120,000 | 0.0% | 0.18% | +6.5% |
| Q2 2020 | $2,860,000 | +4.1% | 120,000 | 0.0% | 0.17% | -42.1% |
| Q1 2020 | $2,748,000 | -25.4% | 120,000 | -7.7% | 0.29% | -13.9% |
| Q4 2019 | $3,682,000 | -99.9% | 130,000 | 0.0% | 0.34% | +17.3% |
| Q3 2019 | $2,793,700,000 | +12.7% | 130,000 | +52.9% | 0.29% | +24.6% |
| Q2 2019 | $2,479,450,000 | – | 85,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $562,187,000 | 75.80% |
| RTW INVESTMENTS, LP | 3,544,248 | $118,697,000 | 2.86% |
| Cormorant Asset Management, LP | 1,537,807 | $51,501,000 | 1.98% |
| Redmile Group, LLC | 2,549,506 | $85,383,000 | 1.57% |
| Birchview Capital, LP | 40,000 | $1,340,000 | 0.45% |
| HighVista Strategies LLC | 17,082 | $572,000 | 0.42% |
| Perceptive Advisors | 671,978 | $22,505,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,490,153 | $49,905,000 | 0.31% |
| Artal Group S.A. | 270,750 | $9,067,000 | 0.22% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 323 | $11,000 | 0.20% |